BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gupta N, Bostrom AG, Kirschner BS, Cohen SA, Abramson O, Ferry GD, Gold BD, Winter HS, Baldassano RN, Smith T, Heyman MB. Presentation and disease course in early- compared to later-onset pediatric Crohn's disease. Am J Gastroenterol 2008;103:2092-8. [PMID: 18796101 DOI: 10.1111/j.1572-0241.2008.02000.x] [Cited by in Crossref: 99] [Cited by in F6Publishing: 78] [Article Influence: 7.1] [Reference Citation Analysis]
Number Citing Articles
1 Turner D, Muise AM. Very Early Onset IBD: How Very Different 'on Average'? J Crohns Colitis 2017;11:517-8. [PMID: 28082310 DOI: 10.1093/ecco-jcc/jjw217] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Gupta N, Bostrom AG, Kirschner BS, Ferry GD, Gold BD, Cohen SA, Winter HS, Baldassano RN, Abramson O, Smith T. Incidence of stricturing and penetrating complications of Crohn’s disease diagnosed in pediatric patients. Inflamm Bowel Dis. 2010;16:638-644. [PMID: 19760783 DOI: 10.1002/ibd.21099] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
3 Ashton JJ, Ennis S, Beattie RM. Early-onset paediatric inflammatory bowel disease. The Lancet Child & Adolescent Health 2017;1:147-58. [DOI: 10.1016/s2352-4642(17)30017-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]
4 Montoro-Huguet MA, Belloc B, Domínguez-Cajal M. Small and Large Intestine (I): Malabsorption of Nutrients. Nutrients 2021;13:1254. [PMID: 33920345 DOI: 10.3390/nu13041254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Bequet E, Sarter H, Fumery M, Vasseur F, Armengol-Debeir L, Pariente B, Ley D, Spyckerelle C, Coevoet H, Laberenne JE. Incidence and Phenotype at Diagnosis of Very-early-onset Compared with Later-onset Paediatric Inflammatory Bowel Disease: A Population-based Study [1988-2011]. J Crohns Colitis. 2017;11:519-526. [PMID: 28453757 DOI: 10.1093/ecco-jcc/jjw194] [Cited by in Crossref: 9] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
6 Crowley E, Muise A. Inflammatory Bowel Disease. Gastroenterology Clinics of North America 2018;47:755-72. [DOI: 10.1016/j.gtc.2018.07.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
7 Seemann NM, King SK, Elkadri A, Walters T, Fish J, Langer JC. The operative management of children with complex perianal Crohn's disease. Journal of Pediatric Surgery 2016;51:1993-7. [DOI: 10.1016/j.jpedsurg.2016.09.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
8 Zaharie R, Tantau A, Zaharie F, Tantau M, Gheorghe L, Gheorghe C, Gologan S, Cijevschi C, Trifan A, Dobru D, Goldis A, Constantinescu G, Iacob R, Diculescu M; IBDPROSPECT Study Group. Diagnostic Delay in Romanian Patients with Inflammatory Bowel Disease: Risk Factors and Impact on the Disease Course and Need for Surgery. J Crohns Colitis. 2016;10:306-314. [PMID: 26589956 DOI: 10.1093/ecco-jcc/jjv215] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 5.1] [Reference Citation Analysis]
9 Eszter Müller K, Laszlo Lakatos P, Papp M, Veres G. Incidence and paris classification of pediatric inflammatory bowel disease. Gastroenterol Res Pract 2014;2014:904307. [PMID: 24778643 DOI: 10.1155/2014/904307] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
10 Benchimol EI, To T, Griffiths AM, Rabeneck L, Guttmann A. Outcomes of pediatric inflammatory bowel disease: socioeconomic status disparity in a universal-access healthcare system. J Pediatr. 2011;158:960-967.e1-4. [PMID: 21227449 DOI: 10.1016/j.jpeds.2010.11.039] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 4.7] [Reference Citation Analysis]
11 Oliva-Hemker M, Hutfless S, Al Kazzi ES, Lerer T, Mack D, LeLeiko N, Griffiths A, Cabrera J, Otley A, Rick J. Clinical Presentation and Five-Year Therapeutic Management of Very Early-Onset Inflammatory Bowel Disease in a Large North American Cohort. J Pediatr. 2015;167:527-532.e1-3. [PMID: 25982142 DOI: 10.1016/j.jpeds.2015.04.045] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 7.3] [Reference Citation Analysis]
12 Canova C, Ludvigsson JF, Di Domenicantonio R, Zanier L, Barbiellini Amidei C, Zingone F. Perinatal and Antibiotic Exposures and the Risk of Developing Childhood-Onset Inflammatory Bowel Disease: A Nested Case-Control Study Based on a Population-Based Birth Cohort. Int J Environ Res Public Health 2020;17:E2409. [PMID: 32252276 DOI: 10.3390/ijerph17072409] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
13 Rogler D, Fournier N, Pittet V, Bühr P, Heyland K, Friedt M, Koller R, Rueger V, Herzog D, Nydegger A, Schäppi M, Schibli S, Spalinger J, Rogler G, Braegger CP; Swiss IBD Cohort Study Group. Coping is excellent in Swiss Children with inflammatory bowel disease: results from the Swiss IBD cohort study. J Crohns Colitis 2014;8:409-20. [PMID: 24230970 DOI: 10.1016/j.crohns.2013.10.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
14 Arcos-machancoses J, Donat-aliaga E, Polo-miquel B, Masip-simó E, Ribes-koninckx C, Pereda-pérez A. Retraso diagnóstico en la enfermedad inflamatoria intestinal pediátrica. Descripción y estudio de los factores de riesgo. Anales de Pediatría 2015;82:247-54. [DOI: 10.1016/j.anpedi.2014.05.024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Srivastava A, Sathiyasekharan M, Jagadisan B, Bolia R, Peethambaran M, Mammayil G, Acharya B, Malik R, Sankaranarayanan S, Biradar V, Malhotra S, Philip M, Poddar U, Yachha SK. Paediatric inflammatory bowel disease in India: a prospective multicentre study. Eur J Gastroenterol Hepatol 2020;32:1305-11. [PMID: 32796356 DOI: 10.1097/MEG.0000000000001859] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Assa A, Rinawi F, Shamir R. The Long-Term Predictive Properties of the Paris Classification in Paediatric Inflammatory Bowel Disease Patients. J Crohns Colitis. 2018;12:39-47. [PMID: 28961726 DOI: 10.1093/ecco-jcc/jjx125] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
17 Barbiellini Amidei C, Zingone F, Zanier L, Canova C. Risk of Prevalent Asthma among Children Affected by Inflammatory Bowel Disease: A Population-Based Birth Cohort Study. Int J Environ Res Public Health 2020;17:E4255. [PMID: 32549223 DOI: 10.3390/ijerph17124255] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Schreiber-Dietrich D, Chiorean L, Cui XW, Braden B, Kucharzik T, Jüngert J, Kosiak W, Stenzel M, Dietrich CF. Particularities of Crohn's disease in pediatric patients: current status and perspectives regarding imaging modalities. Expert Rev Gastroenterol Hepatol 2015;9:1313-25. [PMID: 26377445 DOI: 10.1586/17474124.2015.1083420] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
19 Tang WJ, Shi P, Zheng CF, Shi JR, Qiu XX, Wang SN, Huang Y. Special clinical characteristics and outcomes in Chinese pediatric patients with early‐onset Crohn's disease. J Dig Dis 2019;20:539-46. [DOI: 10.1111/1751-2980.12803] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Uslu N, Usta Y, Saltik-Temizel IN, Demir H, Gürakan F, Ozen H, Yüce A. Ineffectiveness of infliximab therapy in severe infantile Crohn's disease. J Crohns Colitis 2010;4:106-9. [PMID: 21122492 DOI: 10.1016/j.crohns.2009.08.004] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 Boualit M, Salleron J, Turck D, Fumery M, Savoye G, Dupas J, Lerebours E, Duhamel A, Merle V, Cortot A, Colombel J, Peyrin-biroulet L, Gower-rousseau C. Long-term Outcome After First Intestinal Resection in Pediatric-onset Crohnʼs Disease: A Population-based Study. Inflammatory Bowel Diseases 2013;19:7-14. [DOI: 10.1002/ibd.23004] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
22 García-Erce JA, Gomollón F, Muñoz M. Blood transfusion for the treatment of acute anaemia in inflammatory bowel disease and other digestive diseases. World J Gastroenterol 2009; 15(37): 4686-4694 [PMID: 19787832 DOI: 10.3748/wjg.15.4686] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
23 Falaiye TO, Mitchell KR, Lu Z, Saville BR, Horst SN, Moulton DE, Schwartz DA, Wilson KT, Rosen MJ. Outcomes following infliximab therapy for pediatric patients hospitalized with refractory colitis-predominant IBD. J Pediatr Gastroenterol Nutr 2014;58:213-9. [PMID: 24048170 DOI: 10.1097/MPG.0b013e3182a98df2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
24 van Wanrooij RLJ, Bontkes HJ, Neefjes-Borst EA, Mulder CJ, Bouma G. Immune-mediated enteropathies: From bench to bedside. J Autoimmun 2021;118:102609. [PMID: 33607573 DOI: 10.1016/j.jaut.2021.102609] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Nasiri S, Kuenzig ME, Benchimol EI. Long-term outcomes of pediatric inflammatory bowel disease. Seminars in Pediatric Surgery 2017;26:398-404. [DOI: 10.1053/j.sempedsurg.2017.10.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
26 Moran CJ, Klein C, Muise AM, Snapper SB. Very early-onset inflammatory bowel disease: gaining insight through focused discovery. Inflamm Bowel Dis. 2015;21:1166-1175. [PMID: 25895007 DOI: 10.1097/mib.0000000000000329] [Cited by in Crossref: 39] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
27 Fang YH, Luo YY, Yu JD, Lou JG, Chen J. Phenotypic and genotypic characterization of inflammatory bowel disease in children under six years of age in China. World J Gastroenterol 2018; 24(9): 1035-1045 [PMID: 29531467 DOI: 10.3748/wjg.v24.i9.1035] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
28 De Greef E, Hoffman I, Smets F, Van Biervliet S, Bontems P, Hauser B, Paquot I, Alliet P, Arts W, Dewit O, De Vos M, Baert F, Bossuyt P, Rahier JF, Franchimont D, Vermeire S, Fontaine F, Louis E, Coche JC, Veereman G; IBD working group of BESPGHAN, BIRD. Paediatric Crohn Disease: Disease Activity and Growth in the BELCRO Cohort After 3 Years Follow-up. J Pediatr Gastroenterol Nutr 2016;63:253-8. [PMID: 26835906 DOI: 10.1097/MPG.0000000000001132] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
29 Lv JJ, Su W, Chen XY, Yu Y, Xu X, Xu CD, Deng X, Huang JB, Wang XQ, Xiao Y. Autosomal recessive 333 base pair interleukin 10 receptor alpha subunit deletion in very early-onset inflammatory bowel disease. World J Gastroenterol 2021; 27(44): 7705-7715 [PMID: 34908808 DOI: 10.3748/wjg.v27.i44.7705] [Reference Citation Analysis]
30 Timmer A, Stark R, Peplies J, Classen M, Laass MW, Koletzko S. Current health status and medical therapy of patients with pediatric-onset inflammatory bowel disease: a survey-based analysis on 1280 patients aged 10-25 years focusing on differences by age of onset. Eur J Gastroenterol Hepatol 2017;29:1276-83. [PMID: 28877085 DOI: 10.1097/MEG.0000000000000956] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
31 Levine A, Turner D, Pfeffer Gik T, Amil Dias J, Veres G, Shaoul R, Staiano A, Escher J, Kolho KL, Paerregaard A, Martin de Carpi J, Veereman Wauters G, Koletzko S, Shevah O, Finnby L, Sladek M. Comparison of outcomes parameters for induction of remission in new onset pediatric Crohn's disease: evaluation of the porto IBD group "growth relapse and outcomes with therapy" (GROWTH CD) study. Inflamm Bowel Dis 2014;20:278-85. [PMID: 24390062 DOI: 10.1097/01.MIB.0000437735.11953.68] [Cited by in Crossref: 53] [Cited by in F6Publishing: 21] [Article Influence: 7.6] [Reference Citation Analysis]
32 Bramuzzo M, Arrigo S, Romano C, Filardi MC, Lionetti P, Agrusti A, Dipasquale V, Paci M, Zuin G, Aloi M, Strisciuglio C, Miele E, Pastore M, Martelossi S, Alvisi P; SIGENP IBD Working Group. Efficacy and safety of infliximab in very early onset inflammatory bowel disease: a national comparative retrospective study. United European Gastroenterol J 2019;7:759-66. [PMID: 31316780 DOI: 10.1177/2050640619847592] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
33 Protásio BKPF, Barbosa CMPMM, Neufeld CB, Buck LD, Laund LSL, Toporovski MS, Visoni TC. Specificities of presentation of Crohn's disease in childhood. Einstein (Sao Paulo) 2018;16:eRC4070. [PMID: 29236792 DOI: 10.1590/S1679-45082017RC4070] [Reference Citation Analysis]
34 Ognibene NM, Basile M, Di Maurizio M, Petrillo G, De Filippi C. Features and perspectives of MR enterography for pediatric Crohn disease assessment. Radiol Med 2016;121:362-77. [PMID: 26838591 DOI: 10.1007/s11547-015-0613-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
35 Levine A, Koletzko S, Turner D, Escher JC, Cucchiara S, de Ridder L, Kolho KL, Veres G, Russell RK, Paerregaard A, Buderus S, Greer ML, Dias JA, Veereman-Wauters G, Lionetti P, Sladek M, Martin de Carpi J, Staiano A, Ruemmele FM, Wilson DC;  European Society of Pediatric Gastroenterology; Hepatology, and Nutrition. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr. 2014;58:795-806. [PMID: 24231644 DOI: 10.1097/mpg.0000000000000239] [Cited by in Crossref: 306] [Cited by in F6Publishing: 195] [Article Influence: 43.7] [Reference Citation Analysis]
36 Seemann NM, Elkadri A, Walters TD, Langer JC. The role of surgery for children with perianal Crohn's disease. J Pediatr Surg 2015;50:140-3. [PMID: 25598111 DOI: 10.1016/j.jpedsurg.2014.10.034] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
37 Kumarasinghe MP, Quek TP, Chau CY, Mustapha NR, Luman W, Ooi CJ. Endoscopic biopsy features and diagnostic challenges of adult Crohn's disease at initial presentation. Pathology. 2010;42:131-137. [PMID: 20085514 DOI: 10.3109/00313020903494979] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
38 Maccioni F, Viola F, Carrozzo F, Di Nardo G, Pino AR, Staltari I, Al Ansari N, Vestri A, Signore A, Marini M, Cucchiara S. Differences in the location and activity of intestinal Crohn's disease lesions between adult and paediatric patients detected with MRI. Eur Radiol 2012;22:2465-77. [PMID: 22926159 DOI: 10.1007/s00330-012-2482-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
39 Colman RJ, Dhaliwal J, Rosen MJ. Predicting Therapeutic Response in Pediatric Ulcerative Colitis-A Journey Towards Precision Medicine. Front Pediatr 2021;9:634739. [PMID: 33681110 DOI: 10.3389/fped.2021.634739] [Reference Citation Analysis]
40 Ashton JJ, Coelho T, Ennis S, Batra A, Afzal NA, Beattie RM. Presenting phenotype of paediatric inflammatory bowel disease in Wessex, Southern England 2010-2013. Acta Paediatr. 2015;104:831-837. [PMID: 25847524 DOI: 10.1111/apa.13017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
41 Eindor-Abarbanel A, Healey GR, Jacobson K. Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood. Int J Mol Sci 2021;22:12506. [PMID: 34830388 DOI: 10.3390/ijms222212506] [Reference Citation Analysis]
42 Kerur B, Benchimol EI, Fiedler K, Stahl M, Hyams J, Stephens M, Lu Y, Pfefferkorn M, Alkhouri R, Strople J, Kelsen J, Siebold L, Goyal A, Rosh JR, LeLeiko N, Van Limbergen J, Guerrerio AL, Maltz R, Karam L, Crowley E, Griffiths A, Heyman MB, Deneau M, Benkov K, Noe J, Mouton D, Pappa H, Galanko JA, Snapper S, Muise AM, Kappelman MD. Natural History of  Very Early Onset Inflammatory Bowel Disease in North America: A Retrospective Cohort Study. Inflamm Bowel Dis 2021;27:295-302. [PMID: 32386060 DOI: 10.1093/ibd/izaa080] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
43 Rosen MJ, Karns R, Vallance JE, Bezold R, Waddell A, Collins MH, Haberman Y, Minar P, Baldassano RN, Hyams JS, Baker SS, Kellermayer R, Noe JD, Griffiths AM, Rosh JR, Crandall WV, Heyman MB, Mack DR, Kappelman MD, Markowitz J, Moulton DE, Leleiko NS, Walters TD, Kugathasan S, Wilson KT, Hogan SP, Denson LA. Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients. Gastroenterology 2017;152:1345-1357.e7. [PMID: 28132889 DOI: 10.1053/j.gastro.2017.01.016] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 9.4] [Reference Citation Analysis]
44 Örtqvist AK, Lundholm C, Halfvarson J, Ludvigsson JF, Almqvist C. Fetal and early life antibiotics exposure and very early onset inflammatory bowel disease: a population-based study. Gut 2019;68:218-25. [PMID: 29321166 DOI: 10.1136/gutjnl-2017-314352] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 12.0] [Reference Citation Analysis]
45 Ricciuto A, Aardoom M, Orlanski-Meyer E, Navon D, Carman N, Aloi M, Bronsky J, Däbritz J, Dubinsky M, Hussey S, Lewindon P, Martín De Carpi J, Navas-López VM, Orsi M, Ruemmele FM, Russell RK, Veres G, Walters TD, Wilson DC, Kaiser T, de Ridder L, Turner D, Griffiths AM; Pediatric Inflammatory Bowel Disease–Ahead Steering Committee. Predicting Outcomes in Pediatric Crohn's Disease for Management Optimization: Systematic Review and Consensus Statements From the Pediatric Inflammatory Bowel Disease-Ahead Program. Gastroenterology 2021;160:403-436.e26. [PMID: 32979356 DOI: 10.1053/j.gastro.2020.07.065] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
46 Seminerio JL, Koutroubakis IE, Ramos-Rivers C, Hashash JG, Dudekula A, Regueiro M, Baidoo L, Barrie A, Swoger J, Schwartz M, Weyant K, Dunn MA, Binion DG. Impact of Obesity on the Management and Clinical Course of Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2015;21:2857-2863. [PMID: 26241001 DOI: 10.1097/mib.0000000000000560] [Cited by in Crossref: 71] [Cited by in F6Publishing: 41] [Article Influence: 11.8] [Reference Citation Analysis]
47 Krupoves A, Mack DR, Seidman EG, Deslandres C, Bucionis V, Amre DK. Immediate and long-term outcomes of corticosteroid therapy in pediatric Crohn's disease patients. Inflamm Bowel Dis 2011;17:954-62. [PMID: 20684012 DOI: 10.1002/ibd.21415] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
48 Short SS, Dubinsky MC, Rabizadeh S, Farrior S, Berel D, Frykman PK. Distinct phenotypes of children with perianal perforating Crohn’s disease. J Pediatr Surg. 2013;48:1301-1305. [PMID: 23845622 DOI: 10.1016/j.jpedsurg.2013.03.027] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
49 Adler J. Can we Improve the Prognostic Value of Phenotype at Inflammatory Bowel Disease Diagnosis? J Crohns Colitis 2020;14:429-30. [PMID: 31639187 DOI: 10.1093/ecco-jcc/jjz126] [Reference Citation Analysis]
50 Wong K, Isaac DM, Wine E. Growth Delay in Inflammatory Bowel Diseases: Significance, Causes, and Management. Dig Dis Sci 2021;66:954-64. [PMID: 33433805 DOI: 10.1007/s10620-020-06759-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
51 Takeuchi I, Kaburaki Y, Arai K, Shimizu H, Hirano Y, Nagata S, Shimizu T. Infliximab for very early-onset inflammatory bowel disease: A tertiary center experience in Japan. J Gastroenterol Hepatol 2020;35:593-600. [PMID: 31425641 DOI: 10.1111/jgh.14836] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
52 Wang XQ, Xiao Y, Xu X, Yu Y, Shan CY, Guo Y, Gong L, Zhou T, Gao SS, Yuan YZ, Wang XJ, Xu CD. Study of disease phenotype and its association with prognosis of paediatric inflammatory bowel disease in China. BMC Pediatr. 2018;18:229. [PMID: 30001197 DOI: 10.1186/s12887-018-1212-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
53 Gasparetto M, Guariso G, Pozza LV, Ross A, Heuschkel R, Zilbauer M. Clinical course and outcomes of diagnosing Inflammatory Bowel Disease in children 10 years and under: retrospective cohort study from two tertiary centres in the United Kingdom and in Italy. BMC Gastroenterol 2016;16:35. [PMID: 26976427 DOI: 10.1186/s12876-016-0455-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
54 Al-Hussaini A, El Mouzan M, Hasosah M, Al-Mehaidib A, ALSaleem K, Saadah OI, Al-Edreesi M. Clinical Pattern of Early-Onset Inflammatory Bowel Disease in Saudi Arabia: A Multicenter National Study. Inflamm Bowel Dis. 2016;22:1961-1970. [PMID: 27104817 DOI: 10.1097/mib.0000000000000796] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 4.8] [Reference Citation Analysis]
55 Moran CJ. Very early onset inflammatory bowel disease. Semin Pediatr Surg 2017;26:356-9. [PMID: 29126503 DOI: 10.1053/j.sempedsurg.2017.10.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
56 von Allmen D. Pediatric Crohn's Disease. Clin Colon Rectal Surg 2018;31:80-8. [PMID: 29487490 DOI: 10.1055/s-0037-1609022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
57 Mager DR, Carroll MW, Wine E, Siminoski K, Macdonald K, Kluthe CL, Medvedev P, Chen M, Wu J, Turner JM, Huynh HQ. Vitamin D status and risk for sarcopenia in youth with inflammatory bowel diseases. Eur J Clin Nutr 2018;72:623-6. [DOI: 10.1038/s41430-018-0105-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
58 Braithwaite KA, Alazraki AL. Use of the star sign to diagnose internal fistulas in pediatric patients with penetrating Crohn disease by MR enterography. Pediatr Radiol 2014;44:926-31. [DOI: 10.1007/s00247-014-2907-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
59 Zheng X, Li M, Wu Y, Lin X, Zhang Z, Zheng W, Wang M. Assessment of pediatric Crohn's disease activity: validation of the magnetic resonance enterography global score (MEGS) against endoscopic activity score (SES-CD). Abdom Radiol (NY) 2020;45:3653-61. [PMID: 32458027 DOI: 10.1007/s00261-020-02590-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
60 Sun S, Ye Z, Zheng S, Chen G, Qian X, Dong K, Huang Y. Surgical treatment of monogenic inflammatory bowel disease: A single clinical center experience. J Pediatr Surg 2019;54:2155-61. [PMID: 31027905 DOI: 10.1016/j.jpedsurg.2019.02.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
61 Banerjee R, Pal P, Girish BG, Reddy DN. Risk factors for diagnostic delay in Crohn's disease and their impact on long-term complications: how do they differ in a tuberculosis endemic region? Aliment Pharmacol Ther 2018;47:1367-74. [DOI: 10.1111/apt.14617] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
62 Hasler S, Zahnd N, Müller S, Vavricka S, Rogler G, Tandjung R, Rosemann T. VAlidation of an 8-item-questionnaire predictive for a positive caLprotectin tEst and Real-life implemenTation in primary care to reduce diagnostic delay in inflammatory bowel disease (ALERT): protocol for a prospective diagnostic study. BMJ Open. 2015;5:e007306. [PMID: 25757949 DOI: 10.1136/bmjopen-2014-007306] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
63 Duricova D, Leroyer A, Savoye G, Sarter H, Pariente B, Aoucheta D, Armengol-debeir L, Ley D, Turck D, Peyrin-biroulet L, Gower-rousseau C, Fumery M, Andre J, Antonietti M, Aouakli A, Armand A, Aroichane I, Assi F, Aubet J, Auxenfants E, Ayafi-ramelot F, Bankovski D, Barbry B, Bardoux N, Baron P, Baudet A, Bazin B, Bebahani A, Becqwort J, Benet V, Benali H, Benguigui C, Ben Soussan E, Bental A, Berkelmans I, Bernet J, Bernou K, Bernou-dron C, Bertot P, Bertiaux-vandaële N, Bertrand V, Billoud E, Biron N, Bismuth B, Bleuet M, Blondel F, Blondin V, Bohon P, Boniface E, Bonnière P, Bonvarlet E, Bonvarlet P, Boruchowicz A, Bostvironnois R, Boualit M, Bouche B, Boudaillez C, Bourgeaux C, Bourgeois M, Bourguet A, Bourienne A, Branche J, Bray G, Brazier F, Breban P, Brihier H, Brung-lefebvre V, Bulois P, Burgiere P, Butel J, Canva J, Canva-delcambre V, Capron J, Cardot F, Carpentier P, Cartier E, Cassar J, Cassagnou M, Castex J, Catala P, Cattan S, Catteau S, Caujolle B, Cayron G, Chandelier C, Chantre M, Charles J, Charneau T, Chavance-thelu M, Chirita D, Choteau A, Claerbout J, Clergue P, Coevoet H, Cohen G, Collet R, Colombel J, Coopman S, Corvisart J, Cortot A, Couttenier F, Crinquette J, Crombe V, Dadamessi I, Dapvril V, Davion T, Dautreme S, Debas J, Degrave N, Dehont F, Delatre C, Delcenserie R, Delette O, Delgrange T, Delhoustal L, Delmotte J, Demmane S, Deregnaucourt G, Descombes P, Desechalliers J, Desmet P, Desreumaux P, Desseaux G, Desurmont P, Devienne A, Devouge E, Devred M, Devroux A, Dewailly A, Dharancy S, Di Fiore A, Djeddi D, Djedir R, Dreher-duwat M, Dubois R, Dubuque C, Ducatillon P, Duclay J, Ducrocq B, Ducrot F, Ducrotté P, Dufilho A, Duhamel C, Dujardin D, Dumant-forest C, Dupas J, Dupont F, Duranton Y, Duriez A, El Achkar K, El Farisi M, Elie C, Elie-legrand M, Elkhaki A, Eoche M, Evrard D, Evrard J, Fatome A, Filoche B, Finet L, Flahaut M, Flamme C, Foissey D, Fournier P, Foutrein-comes M, Foutrein P, Fremond D, Frere T, Fumery M, Gallet P, Gamblin C, Ganga-zandzou S, Gerard R, Geslin G, Gheyssens Y, Ghossini N, Ghrib S, Gilbert T, Gillet B, Godard D, Godard P, Godchaux J, Godchaux R, Goegebeur G, Goria O, Gottrand F, Gower P, Grandmaison B, Groux M, Guedon C, Guillard J, Guillem L, Guillemot F, Guimber D, Haddouche B, Hakim S, Hanon D, Hautefeuille V, Heckestweiller P, Hecquet G, Hedde J, Hellal H, Henneresse P, Heyman B, Heraud M, Herve S, Hochain P, Houssin-bailly L, Houcke P, Huguenin B, Iobagiu S, Ivanovic A, Iwanicki-caron I, Janicki E, Jarry M, Jeu J, Joly J, Jonas C, Katherin F, Kerleveo A, Khachfe A, Kiriakos A, Kiriakos J, Klein O, Kohut M, Kornhauser R, Koutsomanis D, Laberenne J, Laffineur G, Lagarde M, Lannoy P, Lapchin J, Lapprand M, Laude D, Leblanc R, Lecieux P, Leclerc N, Le Couteulx C, Ledent J, Lefebvre J, Lefiliatre P, Legrand C, Le Grix A, Lelong P, Leluyer B, Lenaerts C, Lepileur L, Leplat A, Lepoutre-dujardin E, Leroi H, Leroy M, Lesage J, Lesage X, Lesage J, Lescanne-darchis I, Lescut J, Lescut D, Leurent B, Levy P, Lhermie M, Lion A, Lisambert B, Loire F, Louf S, Louvet A, Luciani M, Lucidarme D, Lugand J, Macaigne O, Maetz D, Maillard D, Mancheron H, Manolache O, Marks-brunel A, Marti R, Martin F, Martin G, Marzloff E, Mathurin P, Mauillon J, Maunoury V, Maupas J, Mesnard B, Metayer P, Methari L, Meurisse B, Meurisse F, Michaud L, Mirmaran X, Modaine P, Monthe A, Morel L, Mortier P, Moulin E, Mouterde O, Mudry J, Nachury M, N’guyen Khac E, Notteghem B, Ollevier V, Ostyn A, Ouraghi A, Ouvry D, Paillot B, Panien-claudot N, Paoletti C, Papazian A, Parent B, Pariente B, Paris J, Patrier P, Paupart L, Pauwels B, Pauwels M, Petit R, Piat M, Piotte S, Plane C, Plouvier B, Pollet E, Pommelet P, Pop D, Pordes C, Pouchain G, Prades P, Prevost A, Prevost J, Quesnel B, Queuniet A, Quinton J, Rabache A, Rabelle P, Raclot G, Ratajczyk S, Rault D, Razemon V, Reix N, Revillon M, Richez C, Robinson P, Rodriguez J, Roger J, Roux J, Rudelli A, Saber A, Savoye G, Schlosseberg P, Segrestin M, Seguy D, Serin M, Seryer A, Sevenet F, Shekh N, Silvie J, Simon V, Spyckerelle C, Talbodec N, Techy A, Thelu J, Thevenin A, Thiebault H, Thomas J, Thorel J, Tielman G, Tode M, Toisin J, Tonnel J, Touchais J, Touze Y, Tranvouez J, Triplet C, Turck D, Uhlen S, Vaillant E, Valmage C, Vanco D, Vandamme H, Vanderbecq E, Vander Eecken E, Vandermolen P, Vandevenne P, Vandeville L, Vandewalle A, Vandewalle C, Vaneslander P, Vanhoove J, Vanrenterghem A, Varlet P, Vasies I, Verbiese G, Vernier-massouille G, Vermelle P, Verne C, Vezilier-cocq P, Vigneron B, Vincendet M, Viot J, Voiment Y, Wacrenier A, Waeghemaecker L, Wallez J, Wantiez M, Wartel F, Weber J, Willocquet J, Wizla N, Wolschies E, Zalar A, Zaouri B, Zellweger A, Ziade C; and the EPIMAD Group. Extra-intestinal Manifestations at Diagnosis in Paediatric- and Elderly-onset Ulcerative Colitis are Associated With a More Severe Disease Outcome: A Population-based Study. Journal of Crohn's and Colitis 2017;11:1326-34. [DOI: 10.1093/ecco-jcc/jjx092] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
64 Coughlan A, Wylde R, Lafferty L, Quinn S, Broderick A, Bourke B, Hussey S; DOCHAS Study. A rising incidence and poorer male outcomes characterise early onset paediatric inflammatory bowel disease. Aliment Pharmacol Ther. 2017;45:1534-1541. [PMID: 28449214 DOI: 10.1111/apt.14070] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
65 Vavricka SR, Spigaglia SM, Rogler G, Pittet V, Michetti P, Felley C, Mottet C, Braegger CP, Rogler D, Straumann A, Bauerfeind P, Fried M, Schoepfer AM; Swiss IBD Cohort Study Group. Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:496-505. [PMID: 21509908 DOI: 10.1002/ibd.21719] [Cited by in Crossref: 138] [Cited by in F6Publishing: 117] [Article Influence: 12.5] [Reference Citation Analysis]
66 Choi S, Moon W. [Pediatric-onset Inflammatory Bowel Disease: What Are Different from Adult in the Treatment?]. Korean J Gastroenterol 2021;77:220-6. [PMID: 34035199 DOI: 10.4166/kjg.2021.067] [Reference Citation Analysis]
67 Jones S, James E, Prasad S. Disease Registries and Outcomes Research in Children: Focus on Lysosomal Storage Disorders. Pediatric Drugs 2011;13:33-47. [DOI: 10.2165/11586860-000000000-00000] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
68 Goodhand J, Hedin CR, Croft NM, Lindsay JO. Adolescents with IBD: the importance of structured transition care. J Crohns Colitis. 2011;5:509-519. [PMID: 22115368 DOI: 10.1016/j.crohns.2011.03.015] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 6.3] [Reference Citation Analysis]
69 de Bie CI, Paerregaard A, Kolacek S, Ruemmele FM, Koletzko S, Fell JM, Escher JC, EUROKIDS Porto IBD Working Group of ESPGHAN. Disease phenotype at diagnosis in pediatric Crohn's disease: 5-year analyses of the EUROKIDS Registry. Inflamm Bowel Dis. 2013;19:378-385. [PMID: 22573581 DOI: 10.1002/ibd.23008] [Cited by in Crossref: 100] [Cited by in F6Publishing: 91] [Article Influence: 11.1] [Reference Citation Analysis]
70 Kelsen JR, Russo P, Sullivan KE. Early-Onset Inflammatory Bowel Disease. Immunol Allergy Clin North Am 2019;39:63-79. [PMID: 30466773 DOI: 10.1016/j.iac.2018.08.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 5.7] [Reference Citation Analysis]
71 Capriati T, Cardile S, Papadatou B, Romano C, Knafelz D, Bracci F, Diamanti A. Pediatric inflammatory bowel disease: specificity of very early onset. Expert Review of Clinical Immunology 2016;12:963-72. [DOI: 10.1080/1744666x.2016.1184571] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
72 Maccioni F, Al Ansari N, Mazzamurro F, Civitelli F, Viola F, Cucchiara S, Catalano C. Detection of Crohn disease lesions of the small and large bowel in pediatric patients: diagnostic value of MR enterography versus reference examinations. AJR Am J Roentgenol. 2014;203:W533-W542. [PMID: 25341168 DOI: 10.2214/ajr.13.11792] [Cited by in Crossref: 32] [Cited by in F6Publishing: 13] [Article Influence: 4.6] [Reference Citation Analysis]
73 Aloi M, Lionetti P, Barabino A, Guariso G, Costa S, Fontana M, Romano C, Lombardi G, Miele E, Alvisi P, Diaferia P, Baldi M, Romagnoli V, Gasparetto M, Di Paola M, Muraca M, Pellegrino S, Cucchiara S, Martelossi S. Phenotype and Disease Course of Early-onset Pediatric Inflammatory Bowel Disease: . Inflammatory Bowel Diseases 2014;20:597-605. [DOI: 10.1097/01.mib.0000442921.77945.09] [Cited by in Crossref: 80] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
74 Zhulina Y, Udumyan R, Henriksson I, Tysk C, Montgomery S, Halfvarson J. Temporal trends in non-stricturing and non-penetrating behaviour at diagnosis of Crohn's disease in Örebro, Sweden: a population-based retrospective study. J Crohns Colitis 2014;8:1653-60. [PMID: 25113899 DOI: 10.1016/j.crohns.2014.07.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
75 Kim KY, Lee EJ, Kim JW, Moon JS, Jang JY, Yang HR, Ko JS. Higher Morbidity of Monogenic Inflammatory Bowel Disease Compared to the Adolescent Onset Inflammatory Bowel Disease. Pediatr Gastroenterol Hepatol Nutr 2018;21:34-42. [PMID: 29383303 DOI: 10.5223/pghn.2018.21.1.34] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
76 Adler J, Dong S, Eder SJ, Dombkowski KJ; ImproveCareNow Pediatric IBD Learning Health System. Perianal Crohn Disease in a Large Multicenter Pediatric Collaborative. J Pediatr Gastroenterol Nutr 2017;64:e117-24. [PMID: 27801750 DOI: 10.1097/MPG.0000000000001447] [Cited by in Crossref: 31] [Cited by in F6Publishing: 10] [Article Influence: 7.8] [Reference Citation Analysis]
77 Jones KD, Hünten-Kirsch B, Laving AM, Munyi CW, Ngari M, Mikusa J, Mulongo MM, Odera D, Nassir HS, Timbwa M, Owino M, Fegan G, Murch SH, Sullivan PB, Warner JO, Berkley JA. Mesalazine in the initial management of severely acutely malnourished children with environmental enteric dysfunction: a pilot randomized controlled trial. BMC Med 2014;12:133. [PMID: 25189855 DOI: 10.1186/s12916-014-0133-2] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 5.4] [Reference Citation Analysis]
78 Ledder O, Catto-Smith AG, Oliver MR, Alex G, Cameron DJ, Hardikar W. Clinical patterns and outcome of early-onset inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2014;59:562-564. [PMID: 24979317 DOI: 10.1097/mpg.0000000000000465] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
79 Belsha D, Bremner R, Thomson M. Indications for gastrointestinal endoscopy in childhood. Arch Dis Child 2016;101:1153-60. [PMID: 27246069 DOI: 10.1136/archdischild-2014-306043] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
80 Schoepfer AM, Dehlavi MA, Fournier N, Safroneeva E, Straumann A, Pittet V, Peyrin-Biroulet L, Michetti P, Rogler G, Vavricka SR; IBD Cohort Study Group. Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rate. Am J Gastroenterol. 2013;108:1744-1753; quiz 1754. [PMID: 23978953 DOI: 10.1038/ajg.2013.248] [Cited by in Crossref: 117] [Cited by in F6Publishing: 100] [Article Influence: 13.0] [Reference Citation Analysis]
81 Logan RM. Links between oral and gastrointestinal health. Curr Opin Support Palliat Care. 2010;4:31-35. [PMID: 19952929 DOI: 10.1097/spc.0b013e32833575e4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]